Keywords: angiomax, achieves, similar, ischemic, results, standard, therapy

Angiomax achieves similar ischemic results to standard therapy

Article | 09 April 2007

Print This

According to US drugmaker The Medicines Company, data from the ACUITY trial show that patients treated with Angiomax (bivalirudin), a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in